The genetics of the serotonin transporter and irritable bowel syndrome

Trends in Molecular Medicine

Volumn 14, Issue 7, 2008, Pages 295-304

  Colucci, Rocchina ^a   Blandizzi, Corrado ^a   Bellini, Massimo ^a   Ghisu, Narcisa ^a   Tonini, Marcello ^b   Del Tacca, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; CITALOPRAM; FLUOXETINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TEGASEROD;

CHEMICAL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG EFFICACY; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; INTESTINE MUCOSA; IRRITABLE COLON; NONHUMAN; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; REVIEW; SEROTONIN RELEASE;

ANIMALS; HUMANS; IRRITABLE BOWEL SYNDROME; MODELS, BIOLOGICAL; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 46049102966     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.05.001     Document Type: Review

References (87)

1. Spiller R. Clinical update: irritable bowel syndrome. Lancet 369 (2007) 1586-1588
2. Palsson O.S., and Drossman D.A. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol. Clin. North Am. 34 (2005) 281-303
3. Gershon M.D. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 39 Suppl. 3 (2005) S184-S193
4. Mawe G.M., et al. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment. Pharmacol. Ther. 23 (2006) 1067-1076
5. Gershon M.D., and Tack J. The serotonin signalling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132 (2007) 397-414
6. Murphy D.L., et al. Serotonin transporter: gene, genetic disorders and pharmacogenetics. Mol. Interv. 4 (2004) 109-123
7. Murphy D.L., and Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 9 (2008) 85-96
8. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol. Motil. 19 Suppl. 2 (2007) 25-31
9. Lesch K.P., and Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1062-1073
10. Usala T., et al. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 18 (2008) 62-73
11. Videlock E.J., and Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol. Clin. North Am. 36 (2007) 665-685
12. Pae C.U., et al. Irritable bowel syndrome in psychiatric perspectives: a comprehensive review. Int. J. Clin. Pract. 61 (2007) 1708-1718
13. Rudnick G. Serotonin transporters - structure and function. J. Membr. Biol. 213 (2006) 101-110
14. Kilic F., et al. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol. Pharmacol. 64 (2003) 440-446
15. Quick M.W. Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int. J. Dev. Neurosci. 20 (2002) 219-224
16. Gill R.K., et al. Function, expression and characterization of the serotonin transporter (SERT) in the native human intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G254-G262
17. Chen J.X., et al. Guinea pig 5-HT transporter: cloning, expression, distribution and function in intestinal sensory reception. Am. J. Physiol. 275 (1998) G433-G448
18. Meier Y., et al. Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab. Dispos. 35 (2007) 590-594
19. 4 receptors in the human stomach and duodenum. Neurogastroenterol. Motil. 19 (2007) 342-348
20. Coates M.D., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126 (2004) 1657-1666
21. Chen J.J., et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J. Neurosci. 21 (2001) 6348-6361
22. Ramamoorthy S., et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2542-2546
23. Battersby S., et al. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untraslated region of the human serotonin transporter gene. J. Neurochem. 72 (1999) 1384-1388
24. Bradley C.C., and Blakely R.D. Alternative splicing of the human serotonin transporter gene. J. Neurochem. 69 (1997) 1356-1367
25. Ozsarac N., et al. Alternative non-coding exons support serotonin transporter mRNA expression in the brain and gut. J. Neurochem. 82 (2002) 336-344
26. Sakai K., et al. Novel variants of murine serotonin transporter mRNA and the promoter activity of its upstream site. Neurosci. Lett. 342 (2003) 175-178
27. Leabman M.K., et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5896-5901
28. Fiskerstrand C.E., et al. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embrionic stem cells. FEBS Lett. 458 (1999) 171-174
29. Wendland J.R., et al. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 11 (2006) 224-226
30. Smits K.M., et al. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol. Psychiatry 9 (2004) 433-441
31. Serretti A., et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry 12 (2007) 247-257
32. Flattem N.L., and Blakely R.D. Modified structure of the human serotonin transporter promoter. Mol. Psychiatry 5 (2000) 110-115
33. Heils A., et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 (1996) 2621-2624
34. Lesch K.P., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
35. Hranilovic D., et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol. Psychiatry 55 (2004) 1090-1094
36. Delbruck S.J.W., et al. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet. Cell Genet. 79 (1997) 214-220
37. Kunugi H., et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol. Psychiatry 2 (1997) 457-462
38. Michaelovsky E., et al. A novel allele in the promoter region of the human serotonin transporter gene. Mol. Psychiatry 4 (1999) 97-99
39. Frisch A., et al. A rare short allele of the serotonin transporter promoter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan origin. Psychiatr. Genet. 10 (2000) 179-183
40. Nakamura M., et al. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5 (2000) 32-38
41. Rasmussen H.B., and Werge T.M. Novel procedure for genotyping of the human serotonin transporter gene-linked polymorphic region (5-HTTLPR) - a region with a high level of allele diversity. Psychiatr. Genet. 17 (2007) 287-291
42. Hu X., et al. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol. Clin. Exp. Res. 29 (2005) 8-16
43. Kraft J.B., et al. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol. Psychiatry 58 (2005) 374-381
44. Sakai K., et al. The silencer activity of the novel human serotonin transporter linked polymorphic regions. Neurosci. Lett. 327 (2002) 13-16
45. Shioe K., et al. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48 (2003) 184-188
46. Lim J.E., et al. Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol. Psychiatry 11 (2006) 649-662
47. Ohman L., and Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig. Liver Sci. 39 (2007) 201-215
48. Tonini M., and Pace F. Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig. Dis. 24 (2006) 59-69
49. Bellini M., et al. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am. J. Gastroenterol. 98 (2003) 2705-2711
50. Little K.Y., et al. Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects. J. Psychiatry Neurosci. 31 (2006) 333-339
51. Camilleri M., et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132 (2007) 17-25
52. Kerckhoffs, A.P.M. et al. (2008) Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol. Motil. http://www.blackwell-synergy.com/loi/nmo 10.1111/j.1365-2982.2008.01100.x
53. O'Hara J.R., et al. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G998-G1007
54. Linden D.R., et al. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol. Motil. 17 (2005) 565-574
55. Foley K.F., et al. IFN-γ and TNF-α decrease serotonin transporter function and expression in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2006) G779-G784
56. Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together?. J. Pediatr. Gastroenterol. Nutr. 45 (2007) S115-S119
57. Wheatcroft J., et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol. Motil. 17 (2005) 863-870
58. Saito Y.A., and Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin. Pharmacother. 7 (2006) 1857-1869
59. Adam B., et al. Mechanisms of disease: genetics of functional gastrointestinal disorders - searching the genes that matter. Nat. Clin. Pract. Gastroenterol. Hepatol. 4 (2007) 102-110
60. Pata C., et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am. J. Gastroenterol. 97 (2002) 1780-1784
61. Yeo A., et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53 (2004) 1452-1458
62. 2-adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53 (2004) 829-837
63. Saito Y.A., et al. A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol. Motil. 19 (2007) 465-470
64. Lee D.Y., et al. Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome. Korean J. Gastroenterol. 43 (2004) 18-22
65. Wang B.M., et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Zhongua Nei Ke Za Zhi 43 (2004) 439-441
66. Park J.M., et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol. Motil. 18 (2006) 995-1000
67. Li Y., et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig. Dis. Sci. 52 (2007) 2942-2949
68. Saito Y.A., et al. The genetics of irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 3 (2005) 1057-1065
69. Van Kerkhoven L.A.S., et al. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment. Pharmacol. Ther. 26 (2007) 979-986
70. Grudell A.B.M., et al. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol. Motil. 20 (2008) 213-219
71. Atkinson W., et al. Altered 5-hydroxytryptamine signalling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 130 (2006) 34-43
72. Jarrett M.E., et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol. Res. Nurs. 9 (2007) 161-169
73. Serretti A., et al. Serotonin transporter gene variants and behavior: a comprehensive review. Curr. Drug Targets 7 (2006) 1659-1669
74. Cho H.J., et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol. Psychiatry 10 (2005) 771-781
75. Camilleri M., et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123 (2002) 425-432
76. Ismair M.G., et al. Tegaserod inhibits the serotonin transporter SERT. Digestion 75 (2007) 90-95
77. Coates M.D., et al. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol. Motil. 18 (2006) 464-471
78. Tack J., et al. Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man. Aliment. Pharmacol. Ther. 23 (2006) 265-274
79. Talley N.J., et al. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig. Dis. Sci. 53 (2008) 108-115
80. Masand P.S., et al. Paroxetine in patients with irritable bowel syndrome: a pilot open-label study. Prim. Care Companion J. Clin. Psychiatry 4 (2002) 12-16
81. Creed F., et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124 (2003) 303-317
82. Kuiken S.D., et al. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin. Gastroenterol. Hepatol. 1 (2003) 219-228
83. Tabas G., et al. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double blind, placebo-controlled trial. Am. J. Gastroenterol. 99 (2004) 914-920
84. Kilkens T.O.C., et al. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Aliment. Pharmacol. Ther. 22 (2005) 865-874
85. Masand P.S., et al. Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study. Prim. Care Companion J. Clin. Psychiatry 7 (2005) 162-166
86. Vahedi H., et al. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment. Pharmacol. Ther. 22 (2005) 381-385
87. Tack J., et al. A controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55 (2006) 1095-1103